Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Firms / L••••• C••••••

L••••• C••••••

Institutional venture firm · probableToronto, Ontariol•••••••••.comSEC exempt reporting adviser

L••••• Ventures, Canada's largest life sciences venture capital firm, invests in healthcare innovators from early-stage to revenue-generating biotech, biotherapeutics, and medical devices. Headquartered in Toronto, Ontario.

venture manager, reported GAV $58M across 8 vehicles

Importance
28
moderate
Active deployment
8
low
Emerging
0
low
Completeness
75
high
Freshness
98
high
Research priority
6
low
Identity and regulatory footprint
Headquarters
Toronto, Ontario, Canadaadviserinfo.sec.gov
Office address
141 ADELAIDE STREET WEST, SUITE 770, Toronto, Ontario, M5H 3L5adviserinfo.sec.gov
Business phone
416-213-4223adviserinfo.sec.gov
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
private fund adviseradviserinfo.sec.gov
Latest Form ADV
Mar 25, 2024
Private funds reported
8 (8 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$57.6Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Owners on Schedule A
8•••••• C••••• I••• (Class B Common Shareholder), C; B••••• G••••• A••••• (L•••••• Partner, Executive), E; L••••• C•••••• I••••••••• M•••••••• I••• (Common Shareholder), E; L••••• C•••••• G•• L••• (Unit Holder), NA; L••••• I•• G• I••• (General Partner), F; L••••• V••••••• I•• G•• L••• (Unit Holder), NA; L••••• I•• G• H••••••• C• (Unit Holder), NA; L••••• I• G• H••••••• I••• (Unit Holder), NA; L••••• V••••••• I• H••••••• L••• (Unit Holder), NA; L••••• I• G• 2••• I••• (Unit Holder), NA; T•••• F•••••••• S••••••• I••• (Class A Common Shareholder), C; L••••• C•••••• •••• I••• (Common Shareholder), E; R•••••••• B••••••• (President), E; H•••• D••••• (Ceo), E; V•• D•• V•••••• P•••• (Ceo), E; L••••• G• I••• (General Partner), F; L••••• G• H••••••• C•• (Unit Holder), NA; L••••• C•••••• •••• I••• (General Partner), F; R••••••• H••••••• I••• (Class C Common Shareholder), B
business phone
416-213-4223adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
2 observed deals
Stated (the firm’s website)
Sectors
biotech, media
Stages
series b, growth
Geography
boston, canada, global
Check size
not stated; DFX does not estimate checks from round sizes
Self-described
venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate 0%follow-on rate 0%new logos, 12 months 2
Funds and vehicles
8 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
L••••• V••••••• I• ••••••••• L•••Fund2022 adv first reportedActive deployment$12.3M
Mar 25, 2024
13unknownunknown
L••••• V••••••• I• H•••••• L•Fund2022 adv first reportedActive deployment$2.3M
Mar 25, 2024
5unknownunknown
L••••• C•••••• I• ••••••••• L•••Fund2018 adv first reportedHarvest$4.2M
Mar 25, 2024
3unknownunknown
L••••• C•••••• I• G•• L•••Feeder or parallel2018 adv first reportedHarvest$2.2M
Mar 25, 2024
5unknownunknown
M•••• L••••• B••••••••• F••• L•••••• P•••••••••FundunknownUnknown$28.2M
Mar 25, 2024
4unknownunknown
L••••• C•••••• I• ••••••••• L•••••• P•••••••••FundunknownUnknown$7.9M
Mar 25, 2024
5unknownunknown
L••••• C•••••• G• L•••••• P•••••••••Feeder or parallelunknownUnknown$334,000
Mar 25, 2024
7unknownunknown
L••••• C•••••• •••• L•••••• P•••••••••FundunknownUnknown$17,783
Mar 25, 2024
2unknownunknown
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
19 current, 7 departed
7 departed (kept with end dates)
Investments on record
2 edges, 2 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
O•••••• M••••portfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
C•••••••••Funding roundparticipantunknown$39.5MunknownMar 19, 2026Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
4 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
17 dated events
  1. Sep 16, 2026
    D••••••• K•••••• (Analyst) no longer on the team page of L••••• C••••••
  2. Sep 16, 2026
    B••• R••••••• (Managing Director) no longer on the team page of L••••• C••••••
  3. Sep 16, 2026
    J•••• J••••• (Partner and COO) no longer on the team page of L••••• C••••••
  4. Sep 16, 2026
    S•••• R•• (Principal) no longer on the team page of L••••• C••••••
  5. Sep 16, 2026
    L• H•• (Partner) no longer on the team page of L••••• C••••••
  6. Mar 30, 2022
    L••••• V••••••• I• H•••••• L• first reported on Form ADV by L••••• C•••••• (Venture Capital Fund), GAV $1,009,000
  7. Mar 30, 2022
    L••••• V••••••• I• ••••••••• L••• first reported on Form ADV by L••••• C•••••• (Venture Capital Fund), GAV $11,303,000
  8. Jan 1, 2022
    L• H•• joined Schedule A of L••••• C•••••• as Principal
  9. Mar 5, 2018
    L••••• C•••••• I• G•• L••• first reported on Form ADV by L••••• C•••••• (Venture Capital Fund)
  10. Mar 5, 2018
    L••••• C•••••• I• ••••••••• L••• first reported on Form ADV by L••••• C•••••• (Venture Capital Fund), GAV $501,000
  11. Mar 24, 2016
    B•••• J•••• U•••••••• (Managing Director) no longer on Schedule A of L••••• C••••••
  12. Mar 27, 2015
    A••••• J•••• H•••• (Senior Associate) no longer on Schedule A of L••••• C••••••
  13. May 14, 2012
    L••••• C•••••• •••• L•••••• P••••••••• first reported on Form ADV by L••••• C•••••• (Venture Capital Fund)
  14. May 14, 2012
    L••••• C•••••• I• ••••••••• L•••••• P••••••••• first reported on Form ADV by L••••• C•••••• (Venture Capital Fund)
  15. May 14, 2012
    M•••• L••••• B••••••••• F••• L•••••• P••••••••• first reported on Form ADV by L••••• C•••••• (Venture Capital Fund)
  16. May 14, 2012
    L••••• C•••••• G• L•••••• P••••••••• first reported on Form ADV by L••••• C•••••• (Venture Capital Fund)
  17. May 14, 2012
    L••••• C•••••• first filed Form ADV (ERA)
Classification history
  1. Sep 12, 2026
    Institutional venture firm (probable, 80%, cls-1)
    venture manager, reported GAV $58M across 8 vehicles
Evidence
48 observations from 2 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC exemption claimedprivate_fund_adviserMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2012-05-14Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2024-03-25Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds1Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone416-213-4223Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
DescriptionL••••• Ventures, C•••••'s largest life sciences venture capital firm, invests in healthcare innovators from early-stage to revenue-generating biotech, biotherapeutics, and medical devices. Headquartered in Toronto, Ontario.
meta description
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionL••••• Ventures, C•••••'s largest life sciences venture capital firm, invests in healthcare innovators from early-stage to revenue-generating biotech, biotherapeutics, and medical devices. Headquartered in Toronto, Ontario.
meta description
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersToronto, Ontario, C•••••Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address141 ADELAIDE STREET WEST, SUITE 770, Toronto, Ontario, M5H 3L5Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Self-described typeventure_capital
L••••• Ventures | Life Sciences Venture Capital | C•••••
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Self-described typeventure_capital
L••••• Ventures | Life Sciences Venture Capital | C•••••
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Legal formCorporationMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://www.lumiraventures.com/portfolio/
1 entries read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Portfolio pagehttps://www.lumiraventures.com/portfolio/
1 entries read
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported8Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$57.6MMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated geographyboston,canada,global
geography words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated geographyboston,canada,global
geography words on the home page
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech,media
sector words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech,media
sector words on the home page
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated stagesseries_b,growth
stage words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated stagesseries_b,growth
stage words on the home page
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://www.lumiraventures.com/our-team/
12 name/title pairs read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://www.lumiraventures.com/our-team/
12 name/title pairs read
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported8Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTP://w••.l•••••••••.comMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Website resolved domainlumiraventures.com
https://l•••••••••.com/
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Website resolved domainlumiraventures.com
https://l•••••••••.com/
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleL••••• Ventures | Life Sciences Venture Capital | C•••••
title tag
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleL••••• Ventures | Life Sciences Venture Capital | C•••••
title tag
Sep 14, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)